PRJNA825325
Gut Microbiota Modulates Radiotherapy-based Antitumor Immune Responses against Hepatocellular Carcinoma
To characterize the gut microbiome related to RT sensitivity, we collected the fecal samples from a prospective longitudinal trial in 24 HCC patients receiving RT for 16s sequencing.